Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Patent Profile: Fate Therapeutics to Receive First U.S. Patent for Induced Pluripotent Stem Cell Technology

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By James DeGiulio -- This week, Fate Therapeutics of San Diego, CA was issued a Notice of Allowance for U.S. Application No. 10/997,146 (U.S. Patent Application Publication No. 2008/0280362), titled "Methods for Reprogramming Somatic Cells." With a priority date of November 26, 2003, the application is believed to contain the earliest allowed claims in the United States for induced pluripotent stem cell technology. Upon issuance, the invention by Rudolf Jaenisch, M.D. (below left), founding member of the Whitehead Institute for Biomedical Research and scientific founder of Fate Therapeutics, will cover methods for generating pluripotent stem cells and compositions for identifying...

Full post as published by Patent Docs on February 10, 2010 (boomark / email).